Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-008-0217-y.pdf
Reference36 articles.
1. Horsewood P, Warkentin TE, Hayward CPM et al (1996) The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 95:161–167
2. Jang IK, Hursting MJ (2005) When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 111:2671–2683
3. Arepally GM, Ortel TL (2006) Heparin-induced thrombocytopenia. N Engl J Med 355:809–817
4. Warkentin TE, Sheppard JA, Horsewood P et al (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703–1708
5. Warkentin TE, Cook RJ, Marder VJ et al (2005) Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 106:3791–3796
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low incidence of anti-PF4/heparin antibodies in patients with acute myelogenous leukaemia;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29
2. Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database;Frontiers in Pharmacology;2023-09-20
3. Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study;International Journal of General Medicine;2023-09
4. The Comparison of Soluble P-selectin, Anti-platelet Factor 4, and Platelet Maximum Aggregation Levels among Coronavirus Disease 2019 Patients;Journal of Applied Hematology;2023
5. Anti‐severe acute respiratory syndrome coronavirus‐2adenoviral‐vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers;British Journal of Haematology;2022-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3